A once-weekly dose of tirzepatide (Mounjaro) can lead to significant, sustained weight loss for up to 3 years in adults with ...

Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...

A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

Novo Nordisk’s Vikrant Shrotriya on accelerating Wegovy’s launch, pricing strategy, and building long-term obesity care ...

Novo Nordisk NVO and Eli Lilly LLY dominate the diabetes and obesity market on the back of the tremendous success of their GLP-1 products. Lilly markets its dual GIP and GLP-1 receptor agonist, ...

A MOTHER has revealed that she lost over four stone after using fat jabs for 22 weeks. Cassie Jane Evans, a mum from the UK, slimmed down from a size 24 to a size 18 thanks to Mounjaro, but ...

including drugmaker Novo Nordisk’s Wegovy and Ozempic, and Eli Lilly and Company’s Mounjaro and Zepbound. The weight loss drugs, originally intended to treat diabetes, work by mimicking a ...

“The risk increase was under 1% for men and just over 2% for women,” says McCall McPherson, PA-C, the founder of Modern Thyroid Clinic who has been prescribing GLP-1s like Ozempic and Mounjaro ...